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In–Vitro Development and Characterisation of a
Superoxide Dismutase-Based Biosensor.
Michelle M. Doran,* Niall J. Finnerty, and John P. Lowry*[a]
A first generation amperometric biosensor for the detection of
superoxide (O2
) was constructed utilising a dip-coating
approach for immobilising the enzyme superoxide dismutase
(SOD, 200 U/mL) onto a Pt electrode. Several dip-coating
procedures were investigated, incorporating styrene, glutaral-
dehyde, bovine serum albumin and polyethylenimine at various
concentrations, in order to develop a simple and reproducible
coating method to maximise the sensitivity of the sensor to
O2
. The optimised design was produced using 5 dip-coatings
and a composite containing 200 U/mL SOD, 0.5% glutaralde-
hyde and 2% polyethylenimine (Sty-(SOD-0.5%GA-2%PEI)5).
This sensor displayed excellent permselective characteristics
with negligible signals produced by 12 of the most common
electroactive species present in brain extracellular fluid, includ-
ing uric acid (UA) which is produced as a by-product of the O2

generating xanthine-xanthine oxidase calibration method. In
addition, it had a response time of ca. 1 s, high sensitivity to
O2
 (0.91  0.02 nA/mM), and an in-vitro limit of detection of ca.
0.063 mM, thus suggesting potential use for neurochemical
monitoring of O2
 in-vivo.
Introduction
The biological reactive oxygen species (ROS) superoxide (O2
) is
generated as a reduced intermediate of molecular oxygen
(O2).
[1,2] Its major source in cells is electron ‘leakage’ from
electron transport chains in the mitochondria and in the
endoplasmic reticulum.[3] Under normal metabolic conditions
ROS are produced at a rate which is matched by the capacity of
tissues to catabolise them.[4,5] However, when their production
exceeds the body’s natural ability to deal with this potentially
cytotoxic process, a variety of pathological conditions may
occur, including stroke, cancer and neurodegeneration.[6,7] This
is true for O2
 which under normal physiological conditions has
a very low nanomolar concentration (10–100 nM)[8] due to the
natural ability of superoxide dismutase (SOD) to catalyse its
dismutation and its high reactivity with other small mole-
cules.[9, 10]
Several techniques for measuring the concentration of O2

indirectly are currently available including electron spin reso-
nance (ESR),[11–13] chemiluminescence[14–17] or certain semiquanti-
tative colorimetric tests. However, none of these are suitable
for direct monitoring in biological tissues and recently electro-
chemical techniques have become popular in order for direct
real-time monitoring of O2
. Several first,[18,19] second[20,21] and
third generation[22–26] O2
 biosensors have been developed for
O2
 monitoring. These sensors have utilised various transducers
including Pt, Au and carbon fibre and various immobilisation
techniques. The most common methods of immobilisation
include entrapment within a membrane, cross-linking, covalent
bonding and physical adsorption.[27–29] Few reports exist for
measuring O2
 levels in-vivo in freely-moving animals because
of its low concentration, fleeting existence and high reactivity
in the in-vivo environment. For a number of years, in-vivo
electrochemistry has been used for the detection of substances
in the living brain.[30,31] Our goal here is to utilise previous
experience to develop a SOD-based biosensor for real-time
neurochemical monitoring of O2
 in-vivo.
In this paper, we report the development of a first
generation biosensor immobilising the enzyme SOD on a Pt
electrode. In order to generate O2
 in the electrochemical cell
this biosensor utilises the classical xanthine-xanthine oxidase
(XOD) reaction.[32] XOD catalyses the univalent and divalent
reduction of molecular O2 generating O2
 and hydrogen
peroxide (H2O2)
[33] resulting in the oxidation of xanthine to uric
acid (UA) as shown below;
Xanthine þ H2O þ O2
XOD
! UAþ O2- þ 2Hþ
The SOD immobilised on the electrode surface then
catalyses the dismutation reaction of the O2
 radical with the
production of O2 and H2O2;
2Hþ þ 2O2-
SOD
! H2O2 þ O2
The H2O2 generated from this enzymatic process is oxidised
at the electrode surface producing the signal generating
current;
H2O2 !2Hþ þ O2 þ 2e-
We initially utilised a dip-coating approach to create a
composite layer of enzyme and stabilising agents in order to
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maximise sensitivity. This is critical in order to enable physio-
logical monitoring of O2
 due to its nanomolar concentrations.
In addition, we incorporated a permselective layer of poly-o-
phenylenediamine (PPD) which facilitated high permeability to
the enzyme generated H2O2
[34,35] and effective rejection of the
UA produced by the oxidation of xanthine in the in-vitro
calibration process. This layer also eliminated signals from
several endogenous interferent species including ascorbic acid
(AA).[36,37] The resultant fast responding, highly selective and
sensitive biosensor has the potential for use in neurochemical
monitoring of O2
 in-vivo.
Results and Discussion
Interferents in Superoxide Calibration
The O2
 radical is generated by the oxidation of xanthine to UA
in the presence of XOD. However, UA is electroactive at the
applied potential of +700 mV and therefore, its contribution to
the biosensor’s signal must be minimised. The inclusion of the
permselective PPD layer prior to modification with the
immobilising/stabilising components resulted in a significant
decrease (P < 0.0001) in the current recorded on addition of
100 mM xanthine: 41.13  3.22 nA (Bare Pt, n=30) to 2.02 
0.17 nA (Pt-PPD, n=16). This result confirms that the UA
current was effectively eliminated by incorporation of the PPD
layer.
Additionally, the spontaneous dismutation of O2
 to H2O2 in
the presence of excess H+ ions is another potential source of
interference which was verified by injecting a single 200 mL
aliquot of catalase into the electrochemical cell after the
addition of 100 mM xanthine. This produced an instantaneous
decrease in current to baseline levels (see Figure 1(a) and (b))
suggesting that the spontaneous dismutation of O2
 is taking
place in the electrochemical cell.
O2
 dismutation by SOD is first order with respect to O2

concentration whereas the spontaneous dismutation is second
order, with a pH dependent second order rate of ~ 105 M1s1
at pH 7.0.[38] The enzyme used in the development of this
biosensor Cu,Zn SOD accelerates the destruction of O2

increasing the rate constant of the dismutation reaction to 2 x
109 M1s1.[39] This suggests that SOD is more efficient at
accelerating the decomposition of O2
 compared with the
spontaneous dismutation, at low concentrations, therefore
suggesting that the enzymatic dismutation of O2
 is more
favourable than the spontaneous dismutation of O2
 in the
electrolyte.
However, despite the need to eliminate the spontaneous
dismutation few reports exist which distinguish this H2O2 from
that generated by the enzymatic SOD reaction. Few research
groups have manufactured first generation biosensors for the
detection of SOD generated H2O2 which employ specific
techniques to differentiate this H2O2 from the H2O2 produced
by spontaneous dismutation. McNeil and co-workers developed
a O2
 biosensor based on SOD-coated platinised carbon
electrodes (PACE). The SOD-coated biosensor was polarised at
+320 mV vs. Ag/AgCl to estimate the H2O2 produced by the
enzyme disproportionation of O2
 through its oxidation
current. Similarly, this biosensor uses a subtraction method to
eliminate the current generated due to the natural dispropor-
tionation of O2
 measured using a second electrode which
consisted of bovine serum albumin (BSA) coated PACE.[40]
Effect of Enzyme Concentration
Synthetic polymers such as styrene and methyl methacrylate
have been successfully used as enzyme immobilisers in the
manufacture of biosensors for neurochemical monitoring. Both
are liquids at room temperature and thus provide a convenient
method for the entrapment of SOD using the dip-coating
Figure 1. (a) Typical raw data trace for a xanthine-XOD calibration on a Pt-PPD sensor. The red arrows indicate sequential 1, 3, 6, 10, 20, 40, 60, 80 and 100 mM
xanthine injections. The green arrow indicates a 200 mL injection of catalase. Calibration performed using CPA at +700 mV vs. SCE. (b) Bar chart showing the
current comparison between I100 mM xanthine (2.597  0.28 nA, n=6) prior to a 200 mL injection of catalase on Pt-PPD sensors. The introduction of catalase
resulted in an instantaneous decrease in current to baseline (0.154  0.028 nA, n=6).
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approach to enzyme loading[41] on the Pt surface. Also, it has
recently been reported that styrene and methyl methacrylate
facilitate increased active enzyme loading in biosensors
designed for neurochemical monitoring.[42]
Designs 1–4 demonstrate the successful immobilisation of
SOD (200 U/mL) by entrapment within a styrene layer on a Pt
1 mm cylinder surface. Table 1 highlights the differences in the
kinetic parameters for each of the four designs tested with
Figure 2(a) showing the Michaelis-Menten plots generated on
addition of xanthine (0–550 mM) for each of the designs. Design
3 (see Figure 2(b)) displayed a significant improvement in
sensitivity (0.53  0.02 nA/mM, n=8) when compared to design
1 (0.13  0.004 nA/mM (n=4), P < 0.0001), design 2 (0.41 
0.02 nA/mM (n=4), P=0.0037) and design 4 (0.30  0.03 nA/
mM (n=4), P < 0.0001).
In designs 5 and 6 we investigated the effect of changing
the concentration of the enzyme solution. The unit of activity
was decreased to 100 U/mL (design 5) and increased to 400 U/
mL (design 6). The ideal enzyme unit of activity was determined
to be 200 U/mL (design 3, see Figure 2(b)) as it produced a
high Vmax current of 15.65  0.24 nA, a Km concentration of
15.47  0.54 mM and a significant increase in sensitivity when
compared to design 5 (0.41  0.03 nA/mM (n=12), P=0.0082)
and design 6 (0.35  0.03 nA/mM (n=12), P=0.0003). All
further design modifications thus utilised 5 layers of 200 U
SOD.
Optimisation of Biosensor Design
The addition of a cross-linking agent such as glutaraldehyde
has been utilised regularly in the construction of biosensors to
improve enzyme stability.[43,44] Glutaraldehyde usually cross-links
with the lysine residues on the enzyme which are typically
located on the protein surface rather than the catalytic site,
Table 1. A comparison of Vmax, Km and LRS for designs 1–16 using varying concentrations of SOD and biosensor components GA, BSA and PEI. The subscript
represents the number of 1 second dips into the SOD solution and various biosensor constituents.
Design Composition n Vmax nA Km mM LRS nA/mM
1 Sty-(SOD(200U))1 4 2.43  0.13 7.57  1.51 0.13  0.004
2 Sty-(SOD(200U))2 4 8.56  0.12 9.08  0.42 0.41  0.02
3 Sty-(SOD(200U))5 8 5.65  0.24 15.47  0.54 0.52  0.02
4 Sty-(SOD(200U))10 4 4.77  0.07 5.08  0.30 0.30  0.03
5 Sty-(SOD(100U)5 12 7.40  0.10 6.86  0.31 0.41  0.03
6 Sty-(SOD(400U)5 12 7.53  0.13 8.28  0.46 0.35  0.03
7 Sty-(SOD-0.5%GA)5 8 5.42  0.06 6.87  0.25 0.42  0.01
8 Sty-(SOD-1%BSA-0.5%GA)5 6 10.33  0.5 15.02  1.46 0.34  0.02
9 Sty-(SOD-0.5%GA-2%PEI)5 17 15.98  0.15 10.33  0.27 0.91  0.02
10 Sty-(SOD-0.5%GA-1%PEI)5 12 10.05  0.10 6.09  0.22 0.85  0.04
11 Sty-(SOD-0.5%GA-3%PEI)5 11 72.76  6.25 100.30  15.26 0.63  0.03
12 Sty-(SOD-0.05%GA-2%PEI)5 8 60.08  5.56 104.70  20.34 0.63. 0.01
13 Sty-(SOD-1%GA-2%PEI)5 7 40.38  1.90 45.90  4.50 0.51  0.01
14 Sty-(SOD-1%BSA-0.5%GA-2%PEI)5 12 12.82  0.14 21.82  0.53 0.28  0.01
15 Sty-(SOD-0.1%BSA-0.5%GA-2%PEI)5 12 5.53  0.06 4.71  0.21 0.70  0.04
16 Sty-(SOD-0.01%BSA-0.5%GA-2%PEI)5 9 19.53  0.49 21.17  1.30 0.61  0.04
Figure 2. (a) The current-concentration profiles for O2
 calibrations (0-154 mM) for biosensor designs 1 (red), 2 (green), 3 (blue), 4 (pink), 5 (orange) and 6
(purple) calibrated in PBS (pH 7.4) buffer solution containing 0.002 U XOD at 21 8C. Calibrations performed using CPA at +700 mV vs. SCE. (b) Bar chart
comparing sensitivities (Linear Region Slope, nA/mM) for biosensor designs 1–6. *p < 0.05; **p < 0.01; ***p < 0.001 vs. Design 3, unpaired Students t-test.
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therefore preserving the protein conformation. Design 7
incorporates glutaraldehyde (0.5%) and resulted in a decrease
in the Km concentration, Vmax and sensitivity when compared to
design 3 (see Table 1). The addition of BSA into a biosensor for
L-Glutamic acid has previously been reported to protect the
enzyme from inactivation during the polymerisation of the
enzyme within a PPD film.[45] The inclusion of lysine rich BSA,
1% into design 8 (see Figure 3(a)) increased the Km concen-
tration to 15.02  1.46 mM, (n=6) and the Vmax current to 10.33
 0.50 nA, (n=6), however a significant decrease (P=0.001) in
sensitivity was observed (0.34  0.02 nA/mM, n=6) when
compared to design 7. In this instance, the glutaraldehyde
crosslinks the BSA in addition to the enzyme thus limiting the
direct enzyme cross-linking, resulting in higher enzyme activity
and stability.
The polybasic positively charged aliphatic amine polyethy-
lenimine (PEI) has also been incorporated into biosensor
designs for both immobilisation[46,47] and stabilisation.[48,49] The
introduction of PEI has proven beneficial in the development of
biosensors for its ability to increase the sensitivity[46] and reduce
the Michaelis constant Km.
[50] These beneficial traits are
attributed to the formation of polyanionic/polycationic com-
plexes between the polycation PEI and the polyanionic enzyme
which reduces the enzyme deactivation.[51] This can also
decrease the electrostatic repulsion between the enzyme
substrate and biosensor components,[46] thus leading to the
formation of a stable configuration resulting in improved long-
term stability of the biosensor. The inclusion of PEI (2%) in
design 9 resulted in a significant increase (P < 0.0001) in
sensitivity to 0.91  0.02 nA/mM (n=17) when compared to
design 3 (0.52  0.02 nA/mM, n=8). This design also yielded a
high Vmax current of 15.98  0.15 nA and a low Km
concentration of 10.33  0.27 mM. Thus, all modified electrodes
presented hereafter incorporate PEI into the design as its
inclusion has resulted in a substantial increase in sensitivity
when compared to designs 1–8.
Concentration Studies
The previous results observed for designs 1–9 demonstrate
that SOD can be successfully immobilised on a Pt surface using
the dip adsorption method. However, O2
 has a low concen-
tration in-vivo and consequently it was essential to investigate
the concentration of the crosslinker and stablisiers in an
attempt to improve the kinetic parameters and sensitivity
further. The introduction of PEI resulted in a marked
enhancement in the kinetic parameters and sensitivity, thus in
designs 10 and 11 we investigated the impact of changing the
PEI concentration to 1% and 3% respectively. Design 10
resulted in a decrease (P=0.1554) in sensitivity to 0.85  0.04
nA/mM, a significant decrease (P < 0.0001) in Vmax to 10.05 
0.10 nA, and a significant (P < 0.0001) decrease in the Km
concentration to 6.09  0.22 mM, when compared to design 9
incorporating the 2% concentration of PEI. Design 11 (3% PEI)
produced poor enzyme kinetics and a high Km concentration
suggesting restricted access of the substrate to the active sites
of the enzyme due to higher diffusional constraints.
Literature reports suggest that the amount of cross-linking
agent used affects the degree or extent of cross-linking, with
low concentrations of glutaraldehyde unable to form sufficient
cross-linkages to effect precipitation of the enzyme.[52] There-
fore, maintaining the PEI concentration at 2%, the glutaralde-
hyde concentration was changed to 0.05% (design 12) and 1%
(design 13) in an attempt to improve the kinetic parameters.
Both designs showed poor enzyme kinetics with high Km
concentrations of 104.70  20.34 mM and 45.90  4.50 mM
respectively. A significant decrease (P < 0.0001 for both
designs) in sensitivity was recorded when compared to design
9. Finally, the addition of BSA into sensor designs incorporating
both GA and PEI was investigated. Three concentrations were
utilised 1% (design 14), 0.1% (design 15) and 0.01% (design
16). The introduction of BSA resulted in a significant decrease
in the sensitivity to 0.28  0.008 nA/mM, (n=12, P < 0.0001) for
Figure 3. (a) The current-concentration profiles for O2
 calibrations (0-154 mM) for biosensor designs 7 (red), 8 (green) and 9 (blue) calibrated in PBS (pH 7.4)
buffer solution containing 0.002 U XOD at 21 8C. Calibrations performed using CPA at +700 mV vs. SCE. (b) Bar chart displaying a comparison of the
sensitivities for biosensor designs 7–9.
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design 14, 0.70  0.04 nA/mM (n=12, P < 0.0001) for design
15, and 0.61  0.04 nA/mM (n=9, P < 0.0001) for design 16.
Dual Sensor Configuration
As mentioned previously, O2
 undergoes spontaneous dismuta-
tion in the electrolyte generating H2O2. However, this contribu-
tion can be eliminated using a dual sensor system. Design 9
demonstrated optimum kinetic parameters and recorded the
highest sensitivity compared to other designs. It was therefore
utilised in the dual sensor design to detect the spontaneously
produced H2O2 and O2
. The second sensor (blank) incorporates
no SOD but was modified with the relevant concentrations and
layers of the other components, i. e. styrene, PEI and glutaralde-
hyde. A subtraction method was utilised in order to find a true
representation of the concentration of O2
 detected at the Pt
surface and Figure 5 illustrates the dual sensor design in
operation. A significant decrease (P < 0.0001) in current from
15.98  0.15 nA (SOD-based electrode) to 2.29  0.40 nA
(blank electrode) was observed at 154 mM O2
 (Figure 5).This
indicates that the spontaneous dismutation of O2
 accounts for
~ 2.30 nA of current generated at the O2 biosensor at 154 mM
O2
. Similarly, a significant decrease (P < 0.0001) in sensitivity
was observed from 0.91  0.06 nA/mM (SOD-based electrode)
to 0.33  0.005 nA/mM (blank sensor). These results show that
the production of H2O2 from the spontaneous dismutation
accounts for only a small proportion of the signal when
compared to the signal from the enzymatic dismutation. For
future use in-vivo, the two electrodes will be implanted in close
proximity to each other and the current from each will be
Figure 4. (a) Comparison of the average linear region slope for O2
 biosensor designs 10–16. Linear region slope values were obtained from the Michaelis-
Menten kinetic curve of the O2
 calibrations (0 – 154 mM) performed using CPA at +700 mV vs. SCE in PBS (pH 7.4) buffer solution containing 0.002 U XOD. (b)
Mean raw data trace for O2
 calibration using design 10 (n=4). Arrows indicate injections yielding concentrations of 0.28, 0.84, 1.68, 2.8, 5.6, 11.2, 16.8, 22.4, 28,
56, 84, 112, 140 and 154 mM O2
.
Figure 5. The current-concentration profiles for
O2
 calibrations performed in PBS (pH 7.4)
buffer solution containing 0.002 U XOD at 21 8C
for the SOD-based electrode (red), blank elec-
trode (green) and dual sensor design (blue).
CPA carried out at +700 mV vs. SCE.
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recorded simultaneously thus facilitating differential discrim-
ination between the H2O2 signal due to the spontaneous
dismutation of O2
 and endogenously produced levels.
Limit of Detection and Time
The limit of detection (LOD) is an important parameter to
consider when designing biosensors to monitor fast transients
in brain analytes whose extracellular fluid (ECF) levels are
invariably low. We calculated the LOD using three times the
error on the lowest calibration concentration (0.28 mM) divided
by the calibration slope (0.91  0.07 nA/mM, Design 9). This
gives a value of 0.063  0.004 mM. In reality one can only use
in-vitro calibration curves to guesstimate concentration
changes in vivo due to differences in background currents and
modifications to the electrode surface resulting from implanta-
tion.[53] Variations in signal in-vivo are usually represented as
relative changes from background. As such, the LOD for in-vivo
sensors is usually determined using the widely applied criterion
of three times the standard deviation of the baseline
signal[37,54,55] (0.026  0.002 mM for Design 9). This range would
suggest that it may be possible to monitor physiological
changes associated with behavioural and/or pharmacological
manipulations in-vivo. We also quantified the concentration
determination error using the mean LRS to determine the
calculated concentration for two standard additions (low and
high, within the linear region) of 0.28 and 11.20 mM O2
. The
values of 0.26 and 10.19 mM respectively are very similar to the
standard values and represent a discrepancy of < 10%.
Response time, which is defined as the time taken for the
response to rise from 10% to 90% of the maximum amplitude
for a fixed concentration step (i. e. t10-90%), is difficult to separate
from the mixing time in in vitro studies. Typical data for the O2

biosensor is shown in Figure 6 and it is clear that the response
time is less than the mixing time and of the order of 1–2
seconds. This is similar to the response times reported for other
Pt-based biosensors,[56,57] and is ca. 5 times faster than values
reported for carbon-based biosensors.[55] Generally, in cases
where the t10-90% values are less than the mixing time in-vitro,
we have found response times in-vivo in the millisecond
range.[58–60]
Interference Studies
The brain is anatomically complicated and contains a wide
range of electroactive surfactants, electrode poisons, electro-
catalysts and a tissue matrix that restricts mass transport to the
electrode[31] as well as a large number of possible interfering
species present at relatively high concentrations including AA,
UA, and the catecholamines. The O2
 radical has a very low
endogenous concentration and therefore it is critical for the
biosensor design to eliminate interferent signals while main-
taining sufficient sensitivity for the target analyte. The
optimised O2
 biosensor (design 9) includes the polymer PPD
in its construction for interference rejection. This polymer has
previously been utilised in the development of biosensors for
the detection of glucose,[59] H2O2
[43] and D-serine,[61] and
demonstrates beneficial traits such as being highly permeable
to the enzyme generated H2O2
[34] while effectively rejecting
interferent species.[36] The selectivity of design 9 to a range of
potential electroactive interferents present in the brain ECF was
examined.
AA is considered the main electroactive interferent mole-
cule present in the brain[62] and with an estimated basal
concentration of 400 mM[63] could readily mask the signal from
the nanomolar levels of O2
. Figure 7 shows the AA sensitivity
recorded at the O2
 biosensor as a function of varying AA
concentration, and the mean current-concentration profile for
Figure 6. A typical example of a response time for a xanthine injection of 40
mM in PBS (pH 7.4) buffer solution at room temperature for the O2
 biosensor.
CPA carried out at +700 mV vs. SCE. Arrow indicates the point of injection
and the blue rectangle symbolises the stirring time.
Figure 7. The sensitivity for the O2
 biosensor as a function of AA
concentration showing significant interference rejection and saturation
characteristics at physiological levels. Inset: The mean current-concentration
for AA calibrations (0-1000 mM) performed in N2 saturated PBS (pH 7.4) at
+700 mV (vs. SCE) and 21 8C using the O2
 biosensor.
Full Papers
4162ChemistrySelect 2017, 2, 4157–4164  2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
AA calibrations which shows saturation of the PPD layer
resulting in a self-blocking phenomenon which has previously
been reported.[36,35]
Other potential interferents tested (Table 2) included the
monoamine neurotransmitters dopamine and 5-hydroxytrypto-
maine (5-HT), their metabolites 3,4-dihydroxyphenylacetic acid
(DOPAC), homovanillic acid (HV) and 5-hydroxyindoleacetic acid
(5-HIAA), dehydroascorbic acid (DHAA), the amino acids L-
tyrosine, L–cysteine, L-tryptophan, the purine metabolite UA
and the anti-oxidant glutathione.
Small negative currents (attributable to baseline drift) were
obtained for most species suggesting no oxidation of the
specific interferent. The administration of L-cysteine, 5-HT and
DOPAC resulted in small negligible oxidation currents. Also,
such signals would be further reduced through co-implantation
with the blank sensor and differential signal analysis.
Conclusion
The detailed in-vitro development of a sensitive O2
 biosensor
is presented. The use of styrene as the immobilisation matrix
facilitated the entrapment of SOD using the dip-coating
approach to enzyme loading. The inclusion of the cross-linker
glutaraldehyde and the stabiliser polyethylenimine produced a
biosensor with excellent sensitivity to O2
 and optimum kinetic
parameters.
The electroactive interferents UA and the H2O2, produced
from the spontaneous dismutation of O2
, contribute to the
electrochemical signal unless eliminated successfully. The
electropolymerisation of o-PD onto the Pt surface provided a
successful method to negate the UA contribution without
impacting negatively on the O2
 sensitivity. A dual sensor
design involving the SOD-based electrode (Sty-(SOD-GA-PEI)5)
and a blank sensor (Sty-(GA-PEI)5) was employed to deal with
the spontaneous dismutation interference. We also demon-
strated the successful rejection of a range of other key
endogenous interferent species such as AA, dopamine and
metabolites. The resultant fast responding, highly selective and
sensitive biosensor has the potential for use in neurochemical
monitoring of O2
 in-vivo.
Supporting Information Summary
The experimental section (materials and methods, working
electrode preparation, instrumentation and data analysis, and
sensor calibration) can be found in the Supporting Information.
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